FDA Drug Approval Updates for Pembrolizumab and Semaglutide

Created by

Tim Zinin

Actor

FDA Approval Feed

Get real-time updates on FDA approvals and recalls for pembrolizumab and semaglutide. Access application status, sponsor details, and recall classifications.

Try for free

FDA Approval Feedzinin/fda-approval-feed

Query

Type

Record type

Billed

+20 fields

Input

Queries(required):pembrolizumab+1

Dataset:both

Limit per source:3

Max concurrency:3

Output fields

Query

Type

Record type

Billed

Brand

Sponsor

Recalling firm

Match type

Evidence confidence

Confidence band

Recommended review

Review priority

Total matches

More exist

Class

Reason

Report date

Source evidence

Data gaps

Partial

Safe for external action

Billing evidence

Observed at

Summary

How it works

Sign up on Apify or log in

The FDA Approval Feed Actor is ready to run with the inputs already set for "FDA Drug Approval Updates for Pembrolizumab and Semaglutide". Sign up or log in and you'll land in Apify Console with a copy of this exact task.

Start the "FDA Drug Approval Updates for Pembrolizumab and Semaglutide" task

The FDA Approval Feed Actor will start running based on the input automatically. You can also change all the input fields, like queries, dataset, and more, to match your specific use case.

Receive the "FDA Drug Approval Updates for Pembrolizumab and Semaglutide" output

Monitor the progress in real time. You will be notified as soon as your dataset is complete and ready for review. Each result includes data such as query, type, record type, and more.